News

SEARCH FIRM NEWS

news February 6, 2019

Prominent Medical Device Attorney, Neil O’Flaherty, Joins Amin Talati in Washington, DC

Neil O’Flaherty has over 28 years of experience involving FDA regulation of medical devices and other products. He has spoken, written and advised extensively on medical device and other FDA-related topics, including the regulation of mobile medical apps and other medical software products, in vitro diagnostics (including genetic and other laboratory tests), human cells, tissues, and […]

news January 17, 2019

Katie Bond Shares Her Thoughts on How to Back Up Advertising Claims and Avoid Risk

New Hope Network recently featured an article published by Katie Bond titled, “How to Back Up Advertising Claims and Avoid Risk”. Katie discusses the recent regulatory landscape with respect to advertising law and provides valuable insight into strategies for mitigating risk. To read the full article, please click HERE.

news January 2, 2019

ATU Arguments Prevail Again in One of the “Biggest Patent Cases of 2018”

Law360 recently named the Federal Circuit’s July ruling in St. Regis Mohawk Tribe, et al. v. Mylan Pharmaceuticals Inc., et al., an appeal from the United States Patent Trial and Appeal Board, as one of the five Biggest Patent Cases of 2018.  Amin Talati Upadhye LLP attorneys submitted Comments of Amici Curiae to the PTAB […]

news December 7, 2018

Amin Talati Bolsters Trademark Practice With Addition of Two IP Leaders

Ms. Roach’s practice focuses exclusively on the trademark lifecycle. Since 2006, she has counseled clients on brand selection, portfolio strategy, trademark application prosecution, brand enforcement and defense, anti-counterfeiting measures, and trademark maintenance stretching from the United States to more than 140 countries around the world. Her extensive knowledge of trademark law helps her clients secure […]

publication September 11, 2018

Don’t let state legislation affecting food, dietary supplements fly under radar

"Don’t let state legislation affecting food, dietary supplements fly under radar". September 11, 2018. Published by Rend Al-Mondhiry in Natural Product Insider.

publication July 24, 2018

Update on the Amarin-ITC Case and the Issues at Stake

"Update on the Amarin-ITC Case and the Issues at Stake". July 24, 2018. Published by Rend Al-Mendhiry, JD and Jennifer M. Adams, JD in Regulatory Affairs Professionals Society.

news July 10, 2018

Amin Talati Upadhye, LLP Team Wins Again at the ITC in False Advertising Case

On July 9, 2018, Partners Joseph Cwik and Erin Conway earned a complete victory at the U.S. International Trade Commission (“ITC”) for the firm’s client ECI Pharmaceuticals LLC (“ECI”) when Complainants Valeant Pharmaceuticals North America LLC and Valeant Pharmaceuticals International, Inc. withdrew all allegations in their Amended Complaint against ECI and moved to terminate their […]

news April 19, 2018

Three’s Company! Al-Mondihry, Bond and Wasserman In One Article On New FTC Leadership

ATU DC’s Rend Al-Mondhiry, Katie Bond, and Ivan Wasserman have been featured in a recent article published by Natural Products Insider assessing the potential issues with dietary supplement advertising by the new FTC leadership under the Republican Administration. To read the full article, please click HERE.

What's Now

Prominent Medical Device Attorney, Neil O’Flaherty, Joins Amin Talati in Washington, DC

Neil O’Flaherty has over 28 years of experience involving FDA regulation of medical devices and other products. He has spoken, written and advised extensively on medical device and other FDA-related topics, including the regulation of mobile MORE >

see all news >